Application no. and date | 16750567.6 (espacenet) (Federated) (European Patent Register), 20160728 | Patent/reg. no. and date | DK/EP 3329002, 20201007 | Publication date | 20180606 | Priority no. and date | US 201562199563 P, 20150731, US 201662287518 P, 20160127 | EP pub. no. and date |
EP 3329002 20180606 | Effective date | | Applicant/owner | Alnylam Pharmaceuticals, Inc., 675 West Kendall Street Henri A. Termeer Square
Cambridge, MA 02142, US | Applicant ref. no. | 1580327 | Inventor | RAJEEV, Kallanthottathil, G., 300 Third Street 3rd Floor
Cambridge, MA 02142, US, ZIMMERMANN, Tracy, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, MAIER, Martin, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, JADHAV, Vasant, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, CHAN, Amy, 300 Third Street 3rd Floor
Cambridge, MA 02142, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | C12N 15/113 (2010.01) | Title | TRANSTHYRETIN (TTR)-IRNA-SAMMENSÆTNINGER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF TIL BEHANDLING ELLER FOREBYGGELSE AF TTR-FORBUNDNE SYGDOMME | Int. application no. | US2016044359 | Int. publication no. | WO2017023660 | Related patent (certificate) | CA 2023 00008 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|